# Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis

> **NCT02970968** · PHASE2 · COMPLETED · sponsor: **Vanda Pharmaceuticals** · enrollment: 152 (actual)

## Conditions studied

- Gastroparesis

## Interventions

- **DRUG:** VLY-686 (Tradipitant)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02970968
- **Lead sponsor:** Vanda Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2018-11
- **Final completion:** 2018-12
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2024-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02970968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02970968, "Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02970968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*